Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,282.80
(
0.62%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
99.71
(
-0.94%
)
Bitcoin
74,025.66
(
0.11%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: zipjet post# 118990

Thursday, 04/28/2011 1:37:44 PM

Thursday, April 28, 2011 1:37:44 PM

Post# of 257253

Is NVS seeking EU approval or any other ex-US approval [for Lovenox]?

The NVS-MNTA collaboration inked in 2006 includes terms for a Lovenox biosimilar in the EU, but the companies have not disclosed plans to commercialize a product. The business proposition for a Lovenox biosimilar in the EU (or elsewhere in the world) is questionable for the reasons cited in #msg-55882487.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now